Etiopathogenesis, diagnosis, and treatment strategies for lymphomatoid papulosis with particular emphasis on the role of the immune system

D Nowicka, P Mertowska, S Mertowski, A Hymos… - Cells, 2022 - mdpi.com
Lymphomatoid papulosis (LyP) is a very rare disease that belongs to the group of CD30+
lymphoproliferative skin diseases. LyP is localized or generalized and usually presents as …

Ustekinumab for the treatment of Crohn's disease: can it find its niche?

EG Simon, S Ghosh, M Iacucci… - Therapeutic advances …, 2016 - journals.sagepub.com
Crohn's disease is an immune-mediated disease that results in panenteric chronic
inflammation in genetically predisposed individuals exposed to an appropriate environment …

Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens.

M Kadin, K Nasu, D Sako, J Said… - The American journal of …, 1985 - ncbi.nlm.nih.gov
A distinctive immunologic phenotype was demonstrated for the characteristic large atypical
cells in skin lesions of 9 patients with lymphomatoid papulosis (LP). Coexpression of …

Adverse reactions to biologics in psoriasis

SJ Lockwood, LM Prens, AB Kimball - Adverse reactions to biologics, 2018 - karger.com
Psoriasis is a chronic autoimmune disease which affects millions of people worldwide. Not
only can psoriasis itself be debilitating and significantly reduce an individual's quality of life …

Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy

A Lis-Swiety, A Skrzypek-Salamon… - Allergology …, 2015 - jstage.jst.go.jp
Ustekinumab is a biological agent that is currently approved for the treatment of moderate to
severe plaque psoriasis. It is a monoclonal antibody that binds the p40 subunit of IL-12 and …

Biologics in dermatology: adverse effects

VN Sehgal, D Pandhi, A Khurana - International Journal of …, 2015 - Wiley Online Library
Biologics are a group of drugs that precisely affect certain specific steps in the immune
response and are an extremely useful group when used in an appropriate setting. However …

Treatment of psoriasis in adults

SR Feldman - UpToDate; Wolters Kluwer Editorial: Alphen aan den …, 2022 - uptodate.com
Psoriasis is a common chronic skin disorder typically characterized by erythematous
papules and plaques with a silver scale, although other presentations occur. Most cases are …

Cutaneous manifestations of reactions to biologics

IM Otani, AS Levin, A Banerji - Current Allergy and Asthma Reports, 2018 - Springer
Abstract Purpose of Review The goal of this paper is to review the major adverse cutaneous
reactions that have been reported to the most commonly used biologics. Recent Findings …

[PDF][PDF] Recurrent erythema annulare centrifugum during ustekinumab treatment in a psoriatic patient

WT Chou, TF Tsai - Acta Dermato-Venereologica, 2013 - pdfs.semanticscholar.org
DISCUSSION Biologic agents are used increasingly for psoriasis control. Among the
biologics, few cutaneous adverse events have been reported for ustekinumab and there is …

Targeting IL-17 and IL-23 in immune mediated renal disease

JR Ghali, SR Holdsworth… - Current Medicinal …, 2015 - ingentaconnect.com
T helper (Th) cells belong to the adaptive immune system and provide an effective and
antigen-specific means of host protection. Th17 cells are a subset of Th cells, characterized …